Mootral

Mars Snacking and Unreasonable Group Announce Unreasonable Food™ Year 1 Venture Cohort Aiming to Redefine the Future of Sustainable Food

Retrieved on: 
Monday, April 22, 2024

CHICAGO, April 22, 2024  /PRNewswire/ -- Today, as part of the Unreasonable Food ™ collaboration, Mars and Unreasonable Group announced the inaugural cohort of companies positioned to re-define our food systems. Mars in collaboration with Unreasonable Group, has helped select fifteen purpose-led, growth stage ventures and their leaders, for their potential to drive impact at scale across the food value chain. This next stage of the Unreasonable Food program will positively impact sustainability goals – including the Mars Net Zero Roadmap and 2030 goals of reducing emissions by 50% and beyond.

Key Points: 
  • CHICAGO, April 22, 2024 /PRNewswire/ -- Today, as part of the Unreasonable Food ™ collaboration, Mars and Unreasonable Group announced the inaugural cohort of companies positioned to re-define our food systems.
  • Mars and Unreasonable Group have selected the first Unreasonable Food ventures, which consists of fifteen cohorts that are headquartered across five continents, operating in nearly forty countries around the globe.
  • "We are excited to welcome these ventures to the Unreasonable Food family," said Daniel Epstein, CEO of Unreasonable Group.
  • For more information about Unreasonable Food and the Year 1 cohort, please visit Unreasonable Food (unreasonablefood.com)

Mootral introduces new methane reduction technology, doubling efficacy using a well-known natural molecule

Retrieved on: 
Monday, December 4, 2023

LONDON, Dec. 4, 2023 /PRNewswire/ -- Mootral, a British biotech company, announces it has completed the in vitro development and testing phase and is now commencing a range of in vivo trials of its Enterix Advanced technology, set to significantly boost the methane reduction efficacy of the original Enterix™ product, while maintaining productivity benefits essential for wide-scale farmer adoption.

Key Points: 
  • This approach builds on Mootral's original technology, which is already in use on UK commercial farms.
  • "A known methane suppressant, iodoform has the same mode of action as bromoform, the active ingredient in some species of seaweed proposed for methane reduction," said Thomas Hafner, Founder and CEO of Mootral.
  • Methane generated from enteric fermentation during cows' digestion accounts for nearly 30 percent of all human-induced methane emissions.
  • Mootral is accelerating the speed of its rollout with a plan to scale into as many as 300 million cows within the next decade.

Mootral introduces new methane reduction technology, doubling efficacy using a well-known natural molecule

Retrieved on: 
Monday, December 4, 2023

LONDON, Dec. 4, 2023 /PRNewswire/ -- Mootral, a British biotech company, announces it has completed the in vitro development and testing phase and is now commencing a range of in vivo trials of its Enterix Advanced technology, set to significantly boost the methane reduction efficacy of the original Enterix™ product, while maintaining productivity benefits essential for wide-scale farmer adoption.

Key Points: 
  • This approach builds on Mootral's original technology, which is already in use on UK commercial farms.
  • "A known methane suppressant, iodoform has the same mode of action as bromoform, the active ingredient in some species of seaweed proposed for methane reduction," said Thomas Hafner, Founder and CEO of Mootral.
  • Methane generated from enteric fermentation during cows' digestion accounts for nearly 30 percent of all human-induced methane emissions.
  • Mootral is accelerating the speed of its rollout with a plan to scale into as many as 300 million cows within the next decade.